Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (241-250 of 348) with videos related to

Pageof 35
Sort By:
Science Advances|June 12, 2020
Reconstructing the time since death using noninvasive thermometry and numerical analysisLeah S Wilk, Richelle J M Hoveling, Gerda J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemiasKen Shiozawa, Takeo Nakanishi, Ming Tan, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Molecular and Cellular Pharmacology|August 16, 2014
Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic ModulationAdam S Reese, Steven J Feigenberg, Azmat Husain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303)Antonius A Miller, Xiaofei F Wang, Lin Gu, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Drug and Alcohol Dependence|October 4, 2020
All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factorsK S Gordon, A Manhapra, S Crystal, et al.
Neuron|October 27, 2021
Repeated hippocampal seizures lead to brain-wide reorganization of circuits and seizure propagation pathwaysManKin Choy, Ehsan Dadgar-Kiani, Greg O Cron, et al.
Clinical Lung Cancer|December 5, 2003
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancerPaul J Hesketh, Christopher J Nauman, Ann M Hesketh, et al.
Pageof 35

Showing results (241-250 of 348) with videos related to

Sort By:
Pageof 35
Science Advances|June 12, 2020
Reconstructing the time since death using noninvasive thermometry and numerical analysisLeah S Wilk, Richelle J M Hoveling, Gerda J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemiasKen Shiozawa, Takeo Nakanishi, Ming Tan, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Molecular and Cellular Pharmacology|August 16, 2014
Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic ModulationAdam S Reese, Steven J Feigenberg, Azmat Husain, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303)Antonius A Miller, Xiaofei F Wang, Lin Gu, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Drug and Alcohol Dependence|October 4, 2020
All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factorsK S Gordon, A Manhapra, S Crystal, et al.
Neuron|October 27, 2021
Repeated hippocampal seizures lead to brain-wide reorganization of circuits and seizure propagation pathwaysManKin Choy, Ehsan Dadgar-Kiani, Greg O Cron, et al.
Clinical Lung Cancer|December 5, 2003
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancerPaul J Hesketh, Christopher J Nauman, Ann M Hesketh, et al.
Pageof 35